Braun Stacey Associates Inc. Decreases Stock Holdings in Celsius Holdings, Inc. (NASDAQ:CELH)

Braun Stacey Associates Inc. decreased its position in Celsius Holdings, Inc. (NASDAQ:CELH) by 40.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 307,828 shares of the company’s stock after selling 211,606 shares during the quarter. Braun Stacey Associates Inc. owned approximately 0.13% of Celsius worth $9,653,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Massachusetts Financial Services Co. MA increased its holdings in Celsius by 231.2% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 3,946,208 shares of the company’s stock valued at $225,289,000 after purchasing an additional 2,754,722 shares during the period. Vanguard Group Inc. raised its holdings in shares of Celsius by 18.7% during the first quarter. Vanguard Group Inc. now owns 16,313,762 shares of the company’s stock valued at $1,352,737,000 after acquiring an additional 2,567,290 shares in the last quarter. Capital International Investors lifted its stake in Celsius by 50.6% in the first quarter. Capital International Investors now owns 3,966,194 shares of the company’s stock worth $328,877,000 after acquiring an additional 1,333,217 shares during the period. Capital Research Global Investors bought a new position in Celsius in the 1st quarter worth $99,746,000. Finally, GQG Partners LLC purchased a new stake in shares of Celsius in the 1st quarter worth about $76,352,000. 60.95% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on CELH shares. UBS Group decreased their price target on shares of Celsius from $50.00 to $45.00 and set a “buy” rating for the company in a research note on Thursday, November 7th. TD Cowen dropped their price target on Celsius from $68.00 to $50.00 and set a “buy” rating on the stock in a research report on Wednesday, August 7th. Roth Mkm decreased their price objective on Celsius from $43.00 to $40.00 and set a “buy” rating for the company in a report on Thursday, November 7th. Jefferies Financial Group reduced their price objective on shares of Celsius from $53.00 to $48.00 and set a “buy” rating for the company in a research note on Thursday, October 10th. Finally, LADENBURG THALM/SH SH dropped their target price on shares of Celsius from $72.00 to $68.00 and set a “neutral” rating on the stock in a research note on Monday, October 21st. One analyst has rated the stock with a sell rating, three have given a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat, Celsius currently has a consensus rating of “Moderate Buy” and a consensus target price of $54.40.

Insider Transactions at Celsius

In related news, CEO John Fieldly sold 74,847 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $32.80, for a total transaction of $2,454,981.60. Following the completion of the sale, the chief executive officer now directly owns 1,812,490 shares of the company’s stock, valued at approximately $59,449,672. This trade represents a 3.97 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 2.20% of the company’s stock.

Celsius Trading Down 4.7 %

Shares of NASDAQ CELH opened at $25.66 on Monday. The stock has a market capitalization of $6.03 billion, a price-to-earnings ratio of 35.64, a P/E/G ratio of 2.95 and a beta of 1.86. Celsius Holdings, Inc. has a 12-month low of $25.50 and a 12-month high of $99.62. The firm’s 50-day moving average price is $31.41 and its 200-day moving average price is $49.47.

Celsius Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.